Images |
Sources |
Experiment + Assay |
Phenotypes |
Human Diseases |
|
fig.6.a
Macrì S et al. (2016)
|
Xla Wt + hmga2 + msx1
NF16 (in situ hybridization)
|
|
|
|
fig.4. i, j
Macrì S et al. (2016)
|
Xla Wt + msx1
NF13-16 (in situ hybridization)
|
|
|
|
fig.4. t
Macrì S et al. (2016)
|
Xla Wt + msx1
NF16 (in situ hybridization)
|
|
|
|
fig.4. u
Macrì S et al. (2016)
|
Xla Wt + msx1
NF16 (in situ hybridization)
|
|
|
|
fig.4. v
Macrì S et al. (2016)
|
Xla Wt + msx1
NF16 (in situ hybridization)
|
|
|
|
fig.6.a
Macrì S et al. (2016)
|
Xla Wt + msx1
NF16 (in situ hybridization)
|
|
|
|
fig.4. l
Macrì S et al. (2016)
|
Xla Wt + msx1
NF25 (in situ hybridization)
|
|
|
|
fig.4. a, b
Macrì S et al. (2016)
|
Xla Wt + msx1 MO
NF13-16 (in situ hybridization)
|
|
|
|
fig.4. q
Macrì S et al. (2016)
|
Xla Wt + msx1 MO
NF16 (in situ hybridization)
|
|
|
|
fig.4. r
Macrì S et al. (2016)
|
Xla Wt + msx1 MO
NF16 (in situ hybridization)
|
|
|